XAIR – Beyond Air Inc
XAIR
$0.16Name : Beyond Air, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $14,847,168.00
EPSttm : -0.69
Beyond Air, Inc.
$0.16
Float Short %
4.26
Margin Of Safety %
Put/Call OI Ratio
0.01
EPS Next Q Diff
0.09
EPS Last/This Y
0.69
EPS This/Next Y
Price
0.16
Target Price
2.25
Analyst Recom
1
Performance Q
-43.08
Relative Volume
0.88
Beta
0.22
Ticker: XAIR
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | XAIR | 0.1833 | 0.01 | 4.29 | 5044 |
2025-06-03 | XAIR | 0.1857 | 0.01 | 1.08 | 5053 |
2025-06-04 | XAIR | 0.1871 | 0.01 | 0.00 | 5076 |
2025-06-05 | XAIR | 0.1825 | 0.01 | 0.00 | 5082 |
2025-06-06 | XAIR | 0.1871 | 0.01 | 0.00 | 5089 |
2025-06-09 | XAIR | 0.186 | 0.01 | 0.01 | 5092 |
2025-06-10 | XAIR | 0.1966 | 0.01 | 0.00 | 5160 |
2025-06-11 | XAIR | 0.198 | 0.01 | 0.00 | 5408 |
2025-06-12 | XAIR | 0.1832 | 0.01 | 0.01 | 5434 |
2025-06-13 | XAIR | 0.1789 | 0.01 | 0.08 | 5561 |
2025-06-16 | XAIR | 0.18 | 0.01 | 0.00 | 5609 |
2025-06-17 | XAIR | 0.2911 | 0.01 | 0.01 | 6118 |
2025-06-18 | XAIR | 0.2038 | 0.01 | 0.02 | 8147 |
2025-06-20 | XAIR | 0.2289 | 0.01 | 0.07 | 8372 |
2025-06-23 | XAIR | 0.1864 | 0.00 | 0.12 | 7552 |
2025-06-24 | XAIR | 0.1839 | 0.01 | 0.13 | 7542 |
2025-06-25 | XAIR | 0.1711 | 0.01 | 3.43 | 7553 |
2025-06-26 | XAIR | 0.1642 | 0.01 | 0.73 | 7567 |
2025-06-27 | XAIR | 0.1668 | 0.01 | 0.33 | 7644 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | XAIR | 0.18 | - | - | 0.00 |
2025-06-03 | XAIR | 0.19 | - | - | 0.00 |
2025-06-04 | XAIR | 0.19 | - | - | 0.00 |
2025-06-05 | XAIR | 0.18 | - | - | 0.00 |
2025-06-06 | XAIR | 0.19 | - | - | 0.00 |
2025-06-09 | XAIR | 0.19 | - | - | 0.00 |
2025-06-10 | XAIR | 0.20 | - | - | 0.00 |
2025-06-11 | XAIR | 0.20 | - | - | 0.00 |
2025-06-12 | XAIR | 0.18 | - | - | 0.00 |
2025-06-13 | XAIR | 0.18 | - | - | 0.00 |
2025-06-16 | XAIR | 0.18 | - | - | 0.00 |
2025-06-17 | XAIR | 0.28 | - | - | 0.00 |
2025-06-18 | XAIR | 0.20 | - | - | 0.00 |
2025-06-20 | XAIR | 0.23 | - | - | 0.00 |
2025-06-23 | XAIR | 0.19 | - | - | 0.00 |
2025-06-24 | XAIR | 0.18 | - | - | 0.00 |
2025-06-25 | XAIR | 0.17 | - | - | 0.00 |
2025-06-26 | XAIR | 0.16 | - | - | 0.00 |
2025-06-27 | XAIR | 0.16 | - | - | 0.00 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
18 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-03 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-04 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-05 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-06 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-09 | XAIR | 9.94 | -6.26 | 3.64 |
2025-06-11 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-12 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-13 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-16 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-17 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-18 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-19 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-20 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-24 | XAIR | 9.94 | -6.26 | 3.49 |
2025-06-25 | XAIR | 9.19 | -6.26 | 3.25 |
2025-06-26 | XAIR | 9.19 | -6.26 | 4.26 |
2025-06-27 | XAIR | 9.19 | -6.26 | 4.26 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
18 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.09
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
9.19
Institutional Transactions
-6.26
Beta
0.22
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
17
Growth Score
39
Sentiment Score
2
Actual DrawDown %
99
Max Drawdown 5-Year %
-99
Target Price
2.25
P/E
Forward P/E
PEG
P/S
4
P/B
0.97
P/Free Cash Flow
EPS
-0.79
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1258.46
Relative Volume
0.88
Return on Equity vs Sector %
-367.2
Return on Equity vs Industry %
-361.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Medical Devices
Employees: 61
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
stock quote shares XAIR – Beyond Air Inc Stock Price stock today
news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch XAIR – Beyond Air Inc yahoo finance google finance
stock history XAIR – Beyond Air Inc invest stock market
stock prices XAIR premarket after hours
ticker XAIR fair value insiders trading